Lauren Temme, PharmD

Sr. Director, Medical Affairs
Gilead Sciences

Disclosure(s): Gilead Sciences, Inc.: Employee, Stocks/Bonds (Private Company)

Poster(s):

• (P-581) Racial/Ethnic Disparities of Renal Outcomes in People with HIV (PWH) on Tenofovir Alafenamide (TAF) Based Antiretroviral Treatment (ART) Regimens in the Real World
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT